Superworth

DBV Technologies price to sales ratio DBVT

Market value divided by revenue over the last twelve months, since 2025.

Today, Nov 2, 2026
148×
Peer median
3.7×

DBV Technologies' price to sales ratio is 148× as of Nov 2, 2026.

The median for 4 biotech stocks of a similar size is 3.7×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far148×105×196×
2025118×52.7×140×

Against its peers

Companies in Biotechnology nearest DBV Technologies' size, closest first, today.

CompanyPrice to sales ratio
DBVTDBV Technologies148×
MGTXMeiraGTx2.3×
PLXProtalix BioTherapeutics2.6×
VCELVericel6.8×
ADMAAdma Biologics4.8×
Peer median3.7×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on DBV Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.